TTA Market Report — Thu 2026-10-01

Opening, midday and closing sessions. Decision all day: NO TRADE

Account$1,005.42

Day+1.20%

SPY day+0.26%

Since start+0.54%

SPY / VOO since+0.44% / +0.42%

Cash61.67%

Closing session (~3:31 PM ET)

Modest up tape with rotation: XLE +1.80%, XLK +1.19%, XLI +0.85% led; XLC -0.68% and XLV -1.12% lagged. QQQ +0.43%, IWM +0.51%, DIA flat. Buying power equals unleveraged buying power at $620.00 (Amendment F.2 passed, F.5 not triggered). No orders since 9/30.

Amendment G

Trigger met at open (Materials, XLB -1.01%), at midday and close (Healthcare, XLV -1.13% / -1.12%). The dip screen ran each time. ISRG is the only name that passed beta and support (-1.17% vs sector -1.12%, 6.4% above its 50-day), but no source could confirm the absence of company-specific news (G.3), and its score of about 54 is under the 55 threshold. Materials names and LLY, SYK, UNH sit below their 50-day averages.

Opportunity pipeline

Name	Move	Valuation reference (Art. 6.4)	Score	Outcome
ISRG	-1.17%	P/E 46.6; target $479.86	≈54	Passed: G.3 unverified, below 55
ACN	+17.9%	P/E 14.6; stale target $190.83	≈53	Waiting: ~13% above target, Art. 22
MAT	+20.0%	P/E 9.3; off 52-wk low	not scored	No verified catalyst, Art. 24
SNPS	+13.3%	P/E 76.8	not scored	Rich, no catalyst
COHR	+10.6%	P/E 69.9	not scored	Sympathy move, no catalyst

CTVA -84% is the Corteva separation (Article 29), not a loss. No candidate reached the 55 bar.

Thesis health — GEV

GREEN. $980.86 vs $967.13 cost; position $385.42 (+$5.42, +1.43%). +3.20% today, back above its 50-day ($965.84). P/E 27.2, stale mean target $1,207: no premium to fair value, so no reduce case. Buy more is unsupported (Articles 13, 14, 22). Hold is affirmative: it beats cash and every candidate seen. Next catalyst: Oct 21 earnings; ex-dividend Oct 27.

Morning and midday

Open: SPY +0.27%, account $994.33. ACN +22% on a verified beat and record bookings, scored about 53, not proposed. Materials dip screen: LIN, SHW, ECL, APD all failed.
Midday: SPY -0.07%, account $1,011.98 with GEV +4.96%. Healthcare dip screen ran; ISRG scored about 54, not proposed.

Notes

Article 6.4 valuation factor applied to every scored candidate and to the GEV exit case.
Weekly Review due Friday 10/2. Article 43 review not due (day 18 of about 30).
Archive batch overdue: 14 dated log files against a 10-file trigger. Nothing deleted; owner action needed.